About Celios 2018-06-23T04:07:32+00:00

We want you to breathe pure, safe air.

Celios Corporation is a private company focused on the research, development, and commercialization of advanced air technologies. We want to bring pure, safe, and breathable air to every part of our lives: indoors and outdoors, at home and in public. The unique advantage of our proprietary and scalable technology is the ability to capture ultra-fine particulate matter down to 10 nanometers in size with portable, lightweight devices.

These devices will be sold into three global marketplaces: retail, industrial and healthcare/medical. There are numerous global organization studies and peer-reviewed medical and clinical studies that have documented the effects of both indoor and outdoor pollution, hazardous chemicals, molds, allergens and life-threatening bacteria and viruses that can make you sick, lead to developing chronic diseases and even cases where exposures can lead to death.

Celios Leadership Team

Dr. Neil Campbell
Dr. Neil CampbellChairman, President, & CEO

Dr. Neil Campbell founded Celios and oversees its strategic vision and daily operations. Having commercialized over 275 products and services, he has a solid track record of building public and private businesses in the science/life science and technology sectors at organizations running the gamut from starts-ups to Fortune 500 companies, providing leadership in turnarounds, stagnant growth, emerging-growth and developing-country scenarios. Prior to founding Celios, Neil served as CEO of Helomics, a personalized healthcare company focused on next-generation diagnostics for the oncology field. In addition to actively managing his own global technology development firm focused on the life sciences, artificial intelligence, ICT, IoT and cleantech industries, Neil has been a VC and PE operating partner and has long advised investment funds, family offices, commercial companies and medical charities. Science and technology companies at which he has held senior roles include SuperNova Diagnostics, EntreMed Pharmaceuticals, Life Technologies, IGEN International (now Roche), Celera Genomics, and Abbott Labs. Neil has also held academic appointments at Johns Hopkins Medical Institutes, Hong Kong University of Science and Tech (HKUST), University of Liverpool and University of Baltimore. Neil received his BS-BA from Norwich University, his MA and MBA from Webster University, and his doctorate from the University of Liverpool.

Dane Saglio
Dane SaglioEVP Finance & CFO

Dane is the CFO and key administration operations officer for Celios. Dane brings to Celios more than 30 years of financial management experience in both public and private companies across a number of business sectors. He served as CFO at Helomics, a personalized medicine company in cancer. Prior to that, he held senior financial positions at RegeneRx biopharmaceuticals, New Generation Biofuels, and EntreMed, all public companies in the biotechnology arena. He began his career at Informatics Corp, now Computer Associates International and then at Bressler & Reiner, a DC-based real estate developer and home builder.  Dane has a BS from the University of Maryland is a licensed CPA in Maryland (inactive).  

Mark Friederich
Mark FriederichSVP Strategic Accounts and Medical Markets

Mark heads up the medical marketplace division as well as the strategic customer accounts for Celios. Mark has held leadership roles in the launch and commercialization of more than 35 products.  He also has 10 years of clinical experience in Trauma and Critical Care, primarily at Baylor Medical Center. Most recently he has served as the commercialization expert working with electroCore, Intersect ENT, Adapt, Aeterna Zentaris, and Ariel Precision. Mark is also a specialty reference consultant for three nationally-recognized commercialization and business development firms, as well as a Managed Markets and Government process resource for a legal firm. Prior to such solo-preneurial roles, he was SVP of Global Market Access with Helomics, a live tissue, personalized medicine corporation, where he coordinated the payer engagement and reimbursement efforts in the US and UK while directing the Sales and Marketing teams.  Mark’s experience navigating complex, multi-layered organizations such as the VA-DoD and Kaiser Permanente, have led to successful commercialization strategies for products such as Eylea for Regeneron, Remicade for Johnson & Johnson, and Lovenox for Sanofi Aventis, where he held leadership positions. He has developed a significant network that is deep and wide across multiple clinical and industrial segments. Friederich holds a Bachelor of Science degree from Western Illinois University as well as other significant medical and regulatory certifications. The last 38 years of experience have equipped him with exceptional perspectives for strategy and tactics in the research, development and commercialization of new innovations.

Dr. Iyam Lynch
Dr. Iyam LynchSVP & CTO

Iyam is Celios’ CTO and chief engineering officer for Celios in the particle physics R&D programs. Iyam, a physicist, technologist, and inventor from North Carolina, is an expert in nanotribological interactions pertaining to microfluidic and fine particulate systems, an area in which he has commercial R&D experience. Prior to joining Celios, Iyam served as Chief Technology Officer at Free Air Inc, the company from which Celios acquired its commercial assets via a global asset purchase, where he led global technical and product development. Previously he served as Senior Scientist at Corinthian Ophthalmic. One of Iyam’s most important contributions to his field is the discovery of the fundamental friction laws that govern microscopic particles in various environments.  He is co-inventor of a cutting-edge microfluidic drug delivery device used in precisely dosing medication to a user’s eye.  He is a co-author of over 10 pending and issued patents.  His most recent work includes co-inventing the world’s most efficient particulate powered air respirator, which is now an asset of Celios.  Iyam received his BA and Ph.D. in physics from North Carolina State University.

Ron Helminiak
Ron HelminiakSVP Business Development & Strategic Intelligence

Ron is in charge of business development at Celios and also heads up its science, technology, and business strategic intelligence activities. Ron is a seasoned business development professional with special expertise in building knowledge and awareness to support the development of new markets, products, technologies, and services.  Before joining Celios, he served as Vice President, Business Development and Strategic Intelligence at Helomics, a personalized healthcare company. Previously, he served as an Intelligence Analyst for the FBI where he was recognized as an expert consultant in the geographical and investigative fields. Ron has held many business and marketing positions during his career, including EVP of Sales and Marketing at Hill Top Research; VP for Cerner Life Sciences focused on health economics, risk management, dossier development, due diligence, systematic reviews and meta-analysis generation; Senior Director of Business Development of Capital Genomix; Senior Director of Corporate Development of EntreMed, spearheading corporate planning and marketing strategies to drive commercialization of key products and services while directing business development, marketing, licensing, and sales activities; Commercial Development and Marketing Manager at Celera Genomics, focused on governmental and industrial collaborations utilizing information generated from Celera’s sequencing of the Human Genome; Marketing Manager Infectious Disease, Microbiology, Telesales and Training at Sanofi Diagnostics Pasteur; Product Manager at Incstar; Sales Representative at Baxter Healthcare’s Dade Division; and Sales Representative at Analytab Products. 1984-1999. He started his career as a Laboratory Manager and Instructor for the United States Army. MBA – Marketing Management University of St. Thomas (MN); MA – Management and supervision Central Michigan University; (MI)BA – Psychology, Mathematics and Chemistry Chaminade University (HI); AS  – Laboratory Science Baylor University (TX).

Ryan Sweeney
Ryan SweeneySVP Chief Manufacturing Officer

Ryan heads up the Asian business for Celios and also serves as the global chief manufacturing officer overseeing facilities in China and United States. Ryan has extensive experience and success in product development and manufacturing—from concept to commercialization. He has a full slate of manufacturing skills, including product design, proof of concept, process engineering, scalability, production scheduling, quality control, supply chain management, product spec, SOPs, product launch, foreign market penetration and systems/equipment design.  Ryan successfully started and operated several firms: ACL, a consulting and logistics business in ChengDu, China; Virtus Manufacturing in Xiamen, China; and two holding companies in Hong Kong. Previously he was a project manager for two construction firms in Atlanta, Georgia: Geyer Construction and Beers Construction now Skanska USA, which was the Southeast’s largest contractor. Ryan is a graduate of Georgia Tech with a BS degree in Management. Having spent 16 years living and working in mainland China, Ryan speaks Mandarin and has extensive experience advising organizations on how best to work within Chinese business culture.

Nigel Gaymond
Nigel GaymondManaging Director, Europe

Nigel is responsible for the business affairs of the Celios European operations and business development. Nigel is a progressive international corporate and business development expert, senior adviser, and charismatic leader with diverse experience across the global health and life sciences ecosystem, including industry, government, economic development agencies, research institutes, trade associations, academia and charitable organizations. His particular expertise involves the development, articulation, and implementation of dynamic growth strategies. He draws upon his vast global network to scout for strategic partners, investors, customers, and intelligence in key innovation sectors. His experience includes 20 years running a US-based strategic consultancy serving clients in industry, health systems, academic and government organizations spanning biopharmaceuticals, diagnostics, medical devices, and informatics – in the US, Europe and parts of Asia. In 2010 he returned home from the US to England to lead the UK BioIndustry Association (BIA) where he represented the interests of this important UK sector to the British government, within the European Union and internationally. Nigel’s early career was spent in the diplomatic service at the British Consulate in Boston where he oversaw commercial activities and served as the UK’s lead in the USA for the biotechnology sector. Nigel is the founder and Executive Chairman of British Expats in Life Sciences (BELS), a global, collaborative network comprised of over 3,000 highly-accomplished, British-educated health and life science leaders working at 1,300 organizations in 43 countries outside the UK. Nigel holds a BSc in Linguistic and International Studies (Russian, Swedish and Law) from the University of Surrey and a Masters in Education from Madeley College.

Where We Are

Our office headquarters is in Tampa, Florida in the historic Ybor City district.

We also have offices in Pittsburgh, PA, Winston-Salem, NC, London, UK, and Hong Kong, China.


Please contact us with any questions. The best way to reach us will be by filling out the fields below with as much information as possible so we can quickly direct your question.

At Celios, we take your privacy seriously and will only use your personal information to administer your account and provide the products, services, and communications you have requested from us.